DARK SECRETS: Anavex life | Vintage Vibes

Anavex Life Sciences Says Rett Syndrome Trial Meets Primary & Secondary Goals

Anavex Life Sciences Corp (NASDAQ: AVXL) reported topline data from the Phase 3 AVATAR trial of ANAVEX2-73 (blarcamesine) in adult female patients with Rett syndrome.

Benzinga · Feb 1, 2022